References
- Elagouz M, Stanescu-Segall D, Jackson TL. Uveal effusion syndrome. Surv Ophthalmol 2010;55:134–145
- Shaunak S, Wilkins A, Pilling JB, et al. Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide. J Neurol Neurosurg Psychiatry 1999;66:79–81
- Bianchi M, Castiglioni MG. Refractory generalized edema; An infrequent complication of long-term pergolide treatment for Parkinson disease. Clin Neuropharmacol 2005;28(5):245–246
- Perez-Lloret S, Bondon-Guitton E, Rascol O, et al. Adverse drug reactions to dopamine agonists: A comparative study in the French Pharmacovigilance Database. Movement Disorders 2010;12:1876–1880
- Al-Sereitt MR, Quik RFP, Turner P. The effect of a single oral dose of pergolide on intraocular pressure and pupil diameter. Br J Clin Pharmac 1989;28:263–268
- Potter DE, Burke JA. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res 1983;2:281–288
- Takusagawa HL, Hunter R, Jue A, et al. Bilateral uveal effusion and angle-closure glaucoma associated with bupropion use. Arch Ophthalmol 2012;130(1):120–122